The Oncogenic Significance and Promise of HER3 in Pharmacotherapy

Published: April 25, 2023, 4 a.m.

Host: Helena Yu, MD
\n\n Guest: Makenzi Evangelist, MD
\n\n\n \n

This Expert Exchange webcast is designed to enhance clinicians\u2019 awareness of the function and role of HER3 in emerging treatment strategies for non-small cell lung cancer and metastatic breast cancer.